DiaMedica Therapeutics Inc. (DMAC) Total liabilities

DiaMedica Therapeutics Inc. (DMAC) total liabilities at each fiscal year-end, per SEC filings.

$1.3MFY2019

Fiscal year	Value	YoY
FY2019	$1.3M	—

Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.

Source: SEC XBRL filings · For reference only · Not investment advice

More DMAC financial trends

DMAC Revenue DMAC Net income DMAC Net margin DMAC Gross profit DMAC Gross margin DMAC Operating income DMAC Operating margin DMAC Operating cash flow DMAC Free cash flow DMAC Capital expenditures DMAC Return on equity DMAC Stock buybacks DMAC Dividends paid DMAC Total assets DMAC Shareholders’ equity DMAC overview →